Alpha blockers: Are all created equal?

Urology

Volumn 56, Issue 5 SUPPL. 1, 2000, Pages 20-22

  Debruyne, Frans M J ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PLACEBO; TAMSULOSIN; TERAZOSIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORTHOSTATIC HYPOTENSION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RETROGRADE EJACULATION; REVIEW; SYMPATHETIC NERVE; TRANSURETHRAL RESECTION; URETHRA PRESSURE; URINE FLOW RATE; VERTIGO;

EID: 0034329582     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00744-5     Document Type: Article

References (11)

1. Some clinical implications of adrenergic receptors in the urinary tract
2. Localization and expression of the α(1A-1), α(1B) and α(1D)-adrenoceptors in hyperplastic and non-hyperplastic human prostate
3. Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia
4. The concept of uroselectivity
5. Treatment of benign prostatic hyperplasia with alpha 1-adrenoreceptor antagonists
6. 1-adrenoceptor subtype-specific blockade
7. 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
8. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)
9. Tamsulosin 0.4 mg once daily: Effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
10. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia
11. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia